Podcast
Questions and Answers
What type of approach is required to make a diagnosis of acute myeloid leukaemia (AML)?
What type of approach is required to make a diagnosis of acute myeloid leukaemia (AML)?
- No specific approach is required
- Multi-faceted approach using only laboratory investigations
- Multi-faceted approach combining clinical features and laboratory investigations (correct)
- Single-faceted approach using only clinical features
Which of the following is NOT included in the laboratory investigations required for diagnosing AML?
Which of the following is NOT included in the laboratory investigations required for diagnosing AML?
- Genetic evaluation of cerebrospinal fluid (CSF)
- Morphological evaluation of blood
- Genetic evaluation of blood (correct)
- Immunophenotypic evaluation of bone marrow
What type of genetic evaluation is required for diagnosing AML?
What type of genetic evaluation is required for diagnosing AML?
- Evaluation of bone marrow and CSF only
- Evaluation of blood, bone marrow, and cerebrospinal fluid (CSF) (correct)
- No genetic evaluation is required
- Evaluation of blood and bone marrow only
What type of evaluation is encompassed in the laboratory investigations required for diagnosing AML?
What type of evaluation is encompassed in the laboratory investigations required for diagnosing AML?
What is required to make a diagnosis of acute myeloid leukaemia (AML)?
What is required to make a diagnosis of acute myeloid leukaemia (AML)?
Which type of evaluation is NOT encompassed in the laboratory investigations required for diagnosing AML?
Which type of evaluation is NOT encompassed in the laboratory investigations required for diagnosing AML?
What is an essential component of the laboratory investigations required for diagnosing AML?
What is an essential component of the laboratory investigations required for diagnosing AML?
Which evaluation is crucial for diagnosing acute myeloid leukaemia (AML) alongside clinical features?
Which evaluation is crucial for diagnosing acute myeloid leukaemia (AML) alongside clinical features?